
TRI-P11
TRI‑P11 — Phytotherapeutic Support for Gut Inflammation and Mucosal Repair
Support Your Gut’s Barrier Integrity and Comfort with TRI‑P11
TRI‑P11 is a concentrated herbal formula designed to reduce intestinal inflammation, modulate immune signaling, and promote mucosal healing—helping restore barrier function and digestive comfort.
WHAT’S INSIDE?
A synergistic blend of botanicals selected for anti‑inflammatory, mucoprotective, and barrier‑repair actions:
- Glycyrrhiza glabra (Licorice) — soothes mucosa (calms inflamed gut lining, reduces irritation), modulates immune signaling, and supports epithelial repair.
- Boswellia serrata (Frankincense) — inhibits pro‑inflammatory eicosanoids and supports gut comfort.
- Curcuma longa (Turmeric) — potent anti‑inflammatory antioxidant that downregulates NF‑κB and cytokine cascades.
- Aloe barbadensis (Aloe vera) — mucosal soothing (hydration and protective coating of the intestinal lining) and reparative properties for intestinal lining.
- Chamomilla recutita (Chamomile) — anti‑inflammatory and spasmolytic support for GI irritation.
- Plantago ovata (Psyllium) — soluble fiber that soothes mucosa (gentle bulking and barrier support), supports stool consistency, and promotes barrier health.
- Calendula officinalis (Calendula) — promotes tissue healing and reduces local inflammation.
- Andrographis paniculata — immune‑modulating, anti‑inflammatory herb supportive in gut inflammation models.
WHY CHOOSE TRI‑P11?
- Targets multiple inflammatory pathways (NF‑κB, cytokines, eicosanoids) with evidence‑backed botanicals.
- Combines mucosal soothing (reducing irritation, promoting hydration/protective coating), barrier repair, and symptomatic relief in one formula.
- Designed for adjunctive support in digestive inflammation and barrier dysfunction.
WHO IS IT FOR?
Individuals seeking botanical support for intestinal inflammation, leaky‑gut tendencies, or mucosal irritation. Consult a healthcare provider for chronic GI conditions.
HOW TO USE
Use as directed on the label or per practitioner guidance. If symptoms persist or worsen, seek medical evaluation.

